Leukemia; Jikei University School of Medicine Describes Research in Leukemia
Leukemia; Jikei University School of Medicine Describes Research in Leukemia
About this item
Full title
Leukemia; Jikei University School of Medicine Describes Research in Leukemia
Publisher
Atlanta: NewsRx
Journal title
Cancer Gene Therapy Week, 2011, p.445
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
All registered patients received a standard dose of cytarabine (Ara-C) (100 mg/m[superscript]2 x 7 days), combined with either idarubicin (IDR) (10-12 mg/m[superscript]2 x 3 days) or daunorubicin (DNR) (50 mg/m[superscript]2 x 3-5 days), and then GO (3-5 mg/m[superscript]2 ), which was administered 1 day after the last infusion of IDR (IAG regimen)...
Alternative Titles
Full title
Leukemia; Jikei University School of Medicine Describes Research in Leukemia
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_896273344
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_896273344
Other Identifiers
ISSN
1543-6837
E-ISSN
1543-6829
How to access this item
Log in as a Library member
